Pattern Recognition and Functional Neuroimaging Help to Discriminate Healthy Adolescents at Risk for Mood Disorders from Low Risk Adolescents

Abstract

IntroductionThere are no known biological measures that accurately predict future development of psychiatric disorders in individual at-risk adolescents. We investigated whether machine learning and fMRI could help to: 1. differentiate healthy adolescents genetically at-risk for bipolar disorder and other Axis I psychiatric disorders from healthy adolescents at low risk of developing these disorders; 2. identify those healthy genetically at-risk adolescents who were most likely to develop future Axis I disorders.Methods16 healthy offspring genetically at risk for bipolar disorder and other Axis I disorders by virtue of having a parent with bipolar disorder and 16 healthy, age- and gender-matched low-risk offspring of healthy parents with no history of psychiatric disorders (12–17 year-olds) performed two emotional face gender-labeling tasks (happy/neutral; fearful/neutral) during fMRI. We used Gaussian Process Classifiers (GPC), a machine learning approach that assigns a predictive probability of group membership to an individual person, to differentiate groups and to identify those at-risk adolescents most likely to develop future Axis I disorders.ResultsUsing GPC, activity to neutral faces presented during the happy experiment accurately and significantly differentiated groups, achieving 75% accuracy (sensitivity = 75%, specificity = 75%). Furthermore, predictive probabilities were significantly higher for those at-risk adolescents who subsequently developed an Axis I disorder than for those at-risk adolescents remaining healthy at follow-up.ConclusionsWe show that a combination of two promising techniques, machine learning and neuroimaging, not only discriminates healthy low-risk from healthy adolescents genetically at-risk for Axis I disorders, but may ultimately help to predict which at-risk adolescents subsequently develop these disorders.

Multivariate Classification of Blood Oxygen Level-Dependent fMRI Data with Diagnostic Intention: A Clinical Perspective

“…Only 5 recent studies have tried to overcome this issue by introducing individual confidence measures. 39,48,54,56,57 As seen in Fig 2 and On-line larger body of independent work. The diversity of scientific backgrounds of recent studies is reflected by a striking heterogeneity of reported methodologic details, sample characteristics, validation strategies, and performance measures.…”

A Review of Feature Reduction Techniques in Neuroimaging

“…Previous feature selection applications using RFE in neuroimaging classification tasks include; ASD (Calderoni et al 2012; Duchesnay et al 2011; Ecker et al 2010; Ingalhalikar et al 2011), MDD (Craddock et al, 2009), schizophrenia (Castro et al 2011b), psychosis (Gothelf et al 2011), object recognition in a fMRI task (Hanson and Halchenko, 2008), fragile X syndrome (Hoeft et al 2011), ADHD (Marquand et al 2011), MCI (Nho et al 2010), fMRI spatial patterns (De Martino et al 2008), mood disorders (Mourao-Miranda et al 2012) and AD (Davatzikos et al 2008; Mesrob et al 2008). An interesting variant of RFE, which involves backward-elimination of voxel clusters rather than individual features, has recently been explored (Deshpande et al 2010).…”

Altered neural function to happy faces in adolescents with and at risk for depression

“…Additional exclusion criteria for all participants were: Wechsler Intelligence Test score <80 (Wechsler, 1999), neurological disorders, history of head trauma, medical conditions including epilepsy, stroke, diabetes, lupus and other vascular disorders, substance abuse/dependence, pregnancy, or presence of metal in the body that would contradict an MRI. Imaging data for the depressed adolescents and a subset of the healthy offspring (Mood-risk and HC) recruited into this study have been published previously using this task, with happy and angry faces (Pan et al, 2013) and with happy and fearful faces (Mourao-Miranda et al, 2012), respectively. All participants were scanned at the Brain Imaging Research Center, Pittsburgh and underwent the same imaging protocol (see below).…”